
Sign up to save your podcasts
Or


Daniel Corcos, Ph.D. at Northwestern University, is running the first randomized control trial designed to investigate the effects of moderate- and high-intensity aerobic exercise on disease progression in untreated patients with Parkinson’s, called SPARX3. Listen as Dr. Corcos explains how aerobic exercise is a vital treatment for people living with Parkinson's.
 By Jessica Krauser
By Jessica Krauser4.3
5252 ratings
Daniel Corcos, Ph.D. at Northwestern University, is running the first randomized control trial designed to investigate the effects of moderate- and high-intensity aerobic exercise on disease progression in untreated patients with Parkinson’s, called SPARX3. Listen as Dr. Corcos explains how aerobic exercise is a vital treatment for people living with Parkinson's.

85 Listeners

223 Listeners

146 Listeners

225 Listeners

187 Listeners

29 Listeners

57 Listeners

31 Listeners

2,070 Listeners

111 Listeners

9 Listeners

37 Listeners

5 Listeners

5 Listeners

106 Listeners